Jeremy Shefner, MD (SUNY Upstate Medical University), Jinsy Andrews, MD (Cytokinetics, Inc.), and Andrew Wolff, MD (Cytokinetics, Inc.) discussed rationale and background of the phase IIB trial of tirasmetiv in ALS.
Jeremy Shefner, MD (SUNY Upstate Medical University), Jinsy Andrews, MD (Cytokinetics, Inc.), and Andrew Wolff, MD (Cytokinetics, Inc.) discussed rationale and background of the phase IIB trial of tirasmetiv in ALS.